Changes in the Tear Film With Scleral Contact Lens Wear for Keratoconic Eyes
Primary Purpose
Keratoconus
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
ZenLens
Sponsored by
About this trial
This is an interventional treatment trial for Keratoconus focused on measuring Scleral Contact Lens, Tear Proteases, Tear Cytokines
Eligibility Criteria
Inclusion Criteria:
- Had been diagnosed with keratoconus in at least one eye.
- Is at least 18 years of age and has full legal capacity to volunteer.
- Has read and understood the information consent letter.
- Is willing and able to follow instructions and maintain the appointment schedule.
Exclusion Criteria:
- Is using any topical medications that will affect ocular health.
- Has any ocular pathology or severe insufficiency of lacrimal secretion (severe dry eyes) that would affect the wearing of contact lenses.
- Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye.
- Has any clinically significant lid or conjunctival abnormalities and active neovascularization.
- Is aphakic.
- Has undergone any corneal surgery.
- Is participating in any other type of eye related clinical or research study.
- Has any known allergies or sensitivity to the diagnostic pharmaceuticals or products, such as fluorescein, used in this study.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
ZenLens with Low limbal clearance
ZenLens with High limbal clearance
Arm Description
Scleral contact lens designed to provide approximately 25 microns of limbal clearance.
Scleral contact lens designed to provide approximately 80 microns of limbal clearance.
Outcomes
Primary Outcome Measures
Tear Protein
To measure the level proteases and cytokines in each of the samples using Meso Scale Discovery system (MSD-ECL).
Secondary Outcome Measures
Comfort
Participants will be asked to rate their ocular comfort, dryness, burning and vision with the contact lenses.
Bulbar and limbal hyperemia
The eyes of the participants will be imaged using the Keratograph® 5.
Corneal thickness
Their corneal thickness will be measured with the Visante OCT.
Full Information
NCT ID
NCT02806921
First Posted
June 16, 2016
Last Updated
June 25, 2019
Sponsor
University of Waterloo
Collaborators
Bausch & Lomb Incorporated
1. Study Identification
Unique Protocol Identification Number
NCT02806921
Brief Title
Changes in the Tear Film With Scleral Contact Lens Wear for Keratoconic Eyes
Official Title
Protease and Cytokine Composition in Post Lens Tear Reservoir of Scleral Lenses for Keratoconic Eyes
Study Type
Interventional
2. Study Status
Record Verification Date
June 2019
Overall Recruitment Status
Completed
Study Start Date
August 2016 (Actual)
Primary Completion Date
January 30, 2018 (Actual)
Study Completion Date
February 15, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Waterloo
Collaborators
Bausch & Lomb Incorporated
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to investigate changes in the level of inflammatory mediators in the tear film of scleral contact lens wearers in a keratoconic population.
Detailed Description
Scleral contact lenses are rigid gas permeable lenses designed to rest on the sclera while vaulting over the cornea with a fluid reservoir. The use of scleral contact lenses has become the current standard of practice as a nonsurgical management of corneal ectasia and ocular surface diseases. Cases have been recently presented of scleral lens wearers exhibiting adverse corneal findings and conjunctival injection from lens wear. These findings are likely associated with the mechanical and hypoxic effects due to poor fitting characteristics at the limbal area. Tear film analysis detecting changes in the levels of proteinases and cytokines have helped researchers gain a better understanding of the pathophysiology of complications in soft contact lenses wearers, dry eye, and keratoconus. Ultimately, this study will provide insights in relating scleral lens fitting characteristics and corneal and limbal physiological responses.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Keratoconus
Keywords
Scleral Contact Lens, Tear Proteases, Tear Cytokines
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
13 (Actual)
8. Arms, Groups, and Interventions
Arm Title
ZenLens with Low limbal clearance
Arm Type
Active Comparator
Arm Description
Scleral contact lens designed to provide approximately 25 microns of limbal clearance.
Arm Title
ZenLens with High limbal clearance
Arm Type
Active Comparator
Arm Description
Scleral contact lens designed to provide approximately 80 microns of limbal clearance.
Intervention Type
Device
Intervention Name(s)
ZenLens
Intervention Description
The ZenLens™ semi-scleral lenses are manufactured by Alden Optic Laboratories Inc., Lancaster, NY. They will be made in Boston XO material.
Primary Outcome Measure Information:
Title
Tear Protein
Description
To measure the level proteases and cytokines in each of the samples using Meso Scale Discovery system (MSD-ECL).
Time Frame
2 weeks of lens wear with daily schedule of 6-8 hours.
Secondary Outcome Measure Information:
Title
Comfort
Description
Participants will be asked to rate their ocular comfort, dryness, burning and vision with the contact lenses.
Time Frame
2 weeks of lens wear with daily schedule of 6-8 hours.
Title
Bulbar and limbal hyperemia
Description
The eyes of the participants will be imaged using the Keratograph® 5.
Time Frame
2 weeks of lens wear with daily schedule of 6-8 hours.
Title
Corneal thickness
Description
Their corneal thickness will be measured with the Visante OCT.
Time Frame
2 weeks of lens wear with daily schedule of 6-8 hours.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Had been diagnosed with keratoconus in at least one eye.
Is at least 18 years of age and has full legal capacity to volunteer.
Has read and understood the information consent letter.
Is willing and able to follow instructions and maintain the appointment schedule.
Exclusion Criteria:
Is using any topical medications that will affect ocular health.
Has any ocular pathology or severe insufficiency of lacrimal secretion (severe dry eyes) that would affect the wearing of contact lenses.
Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye.
Has any clinically significant lid or conjunctival abnormalities and active neovascularization.
Is aphakic.
Has undergone any corneal surgery.
Is participating in any other type of eye related clinical or research study.
Has any known allergies or sensitivity to the diagnostic pharmaceuticals or products, such as fluorescein, used in this study.
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Changes in the Tear Film With Scleral Contact Lens Wear for Keratoconic Eyes
We'll reach out to this number within 24 hrs